...
机译:Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
Chinese Acad Med Sci;
Nanjing Med Univ;
Nanjing Med UnivJiangsu Simcere Diagnost Co;
CIRCULATING TUMOR DNA; LIVER-CANCER; DIAGNOSIS; CHEMOEMBOLIZATION; IMMUNOTHERAPY; RESECTION; DYNAMICS; CRITERIA;